Handelsbanken Fonder AB - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 328 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.

Quarter-by-quarter ownership
Handelsbanken Fonder AB ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,929
+21.2%
15,915
+14.5%
0.01%
+22.2%
Q2 2023$1,592
-11.2%
13,902
+6.9%
0.01%
-10.0%
Q1 2023$1,792
+19.2%
13,002
+12.1%
0.01%
+11.1%
Q4 2022$1,503
-99.9%
11,6020.0%0.01%0.0%
Q3 2022$1,282,000
+47.4%
11,6020.0%0.01%
+50.0%
Q2 2022$870,000
-15.0%
11,602
-11.4%
0.01%0.0%
Q1 2022$1,024,000
-13.2%
13,1020.0%0.01%0.0%
Q4 2021$1,180,000
-2.6%
13,1020.0%0.01%0.0%
Q3 2021$1,212,000
+18.9%
13,1020.0%0.01%
+20.0%
Q2 2021$1,019,000
-7.0%
13,102
-10.9%
0.01%
-16.7%
Q1 2021$1,096,000
-88.1%
14,702
-72.9%
0.01%
-89.3%
Q4 2020$9,241,000
+21.4%
54,2020.0%0.06%0.0%
Q3 2020$7,612,000
-56.2%
54,202
-50.0%
0.06%
-24.3%
Q2 2020$17,382,000
+464.2%
108,404
+244.1%
0.07%
+12.1%
Q1 2020$3,081,000
+11.1%
31,500
+46.5%
0.07%
+37.5%
Q4 2019$2,774,000
+71.3%
21,5000.0%0.05%
+45.5%
Q3 2019$1,619,000
-50.4%
21,5000.0%0.03%
-45.0%
Q2 2019$3,267,000
+3.4%
21,500
-18.9%
0.06%
-1.6%
Q1 2019$3,159,000
+9.2%
26,5000.0%0.06%
+5.2%
Q4 2018$2,892,000
-44.9%
26,500
-18.5%
0.06%
-10.8%
Q3 2018$5,249,000
+34.6%
32,500
+10.2%
0.06%
-15.6%
Q2 2018$3,899,000
-21.5%
29,500
-56.0%
0.08%
+48.1%
Q1 2018$4,964,000
+107.5%
67,000
+55.8%
0.05%
+85.7%
Q4 2017$2,392,00043,0000.03%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Perceptive Advisors 2,878,979$69,182,0007.27%
Eventide Asset Management 259,100$6,226,0000.97%
GLADE BROOK CAPITAL PARTNERS LLC 251,000$6,032,0000.93%
IMS Capital Management 32,215$774,0000.91%
Perceptive Advisors 350,000$8,413,0000.88%
Benchmark Capital Advisors 34,900$839,0000.58%
BECK CAPITAL MANAGEMENT, LLC 24,744$636,0000.49%
SABBY MANAGEMENT, LLC 352,100$8,461,0000.47%
Hatteras Alternative Mutual Funds, LLC 39,404$947,0000.46%
Potomac Capital Management, Inc. 22,100$531,0000.45%
View complete list of SAREPTA THERAPEUTICS INC shareholders